174 related articles for article (PubMed ID: 856314)
1. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of an immunological study in urological cancer.
Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
[TBL] [Abstract][Full Text] [Related]
3. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
[No Abstract] [Full Text] [Related]
4. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
5. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Rost A; Kneppenberg U; Rost P
Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
[TBL] [Abstract][Full Text] [Related]
6. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Gerfo PL; Feminella J; Lattimer JK
J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
[No Abstract] [Full Text] [Related]
7. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
Catalona WJ; Chretien PB; Trahan EE
J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
[No Abstract] [Full Text] [Related]
9. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
[No Abstract] [Full Text] [Related]
10. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
[TBL] [Abstract][Full Text] [Related]
11. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
[TBL] [Abstract][Full Text] [Related]
12. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
[No Abstract] [Full Text] [Related]
13. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
14. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
15. Immunological evaluation in patients with urological cancers.
Martinez-Piñeiro JA; Muntanola P; Hidalgo L
Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
[TBL] [Abstract][Full Text] [Related]
16. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
Bianucci P; Pastorino G; De Rossi O
Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
Flamm J; Burkert S
Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
[TBL] [Abstract][Full Text] [Related]
18. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
[TBL] [Abstract][Full Text] [Related]
19. Skin reactivity to dinitrochlorobenzene in cancer patients.
Jassem J; Serkies K
Neoplasma; 1980; 27(5):589-93. PubMed ID: 7231615
[TBL] [Abstract][Full Text] [Related]
20. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
Hering H; Hering FJ; Weidner W
Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
